ClinicalTrials.gg
CompletedNCT03009890DARTUpdated Jan 18, 2023

Surgery vs. Casting for Displaced Articular Radius Fractures in Elderly

An interventional study of Surgery (Open Reduction Internal Fixation) and Cast treatment in Radius Distal Fracture, sponsored by JointResearch. Completed at 1 site in Netherlands. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2023-01-18.

Sponsored by JointResearch · Not applicable, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
138
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 13 studies in Wrist Fractures with a site in Netherlands — 2 open to participants now, 3 under way, none of them phase 3. Wrist Fractures · Netherlands.

Enrollment
2nd of 11
138 · median 86
Started
2017
with 1 other
No phase
10 of 13
2 open now
Registered
6th of 13
by date
Lead sponsor
2 of 13
JointResearch

Among the 13 studies in Wrist Fractures with a site in Netherlands, this one is the 2nd largest by enrollment of the 11 interventional ones that give a count, is one of 2 that started in 2017, is one of 10 with no phase, and was the 6th registered.

Wrist Fractures

330 studies on the registry are indexed under Wrist Fractures; 72 are open to participants now.

Browse Wrist Fractures studies →

Open to participants now

2 of the 13 studies in Wrist Fractures with a site in Netherlands are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Netherlands have not opened yet or have stopped. Only those recruiting at a site in Netherlands →

Who these studies take

Of the 43 Wrist Fractures studies recruiting now, 20 (47%) set no upper age limit and 15 (35%) stop at 75 or younger; 7 take children under 18; 6 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Wrist Fractures with a site in Netherlands, or all of them as a file.
02

Study summary

Objective: to compare the functional outcome after open reduction and internal fixation with non-operative cast treatment for elderly patients with displaced intra-articular distal radius fractures.

Read the detailed description

Rationale: there is no consensus about the optimal treatment of displaced intra-articular distal radius fractures in elderly patients. To ensure optimal functional outcome there is a tendency to operate. However, there is no evidence that supports the surgical treatment of patients aged 65 years or older and in the absence of clinical trials it stays unclear how elderly patients with intra-articular fractures should be treated.

Study design: multi-center randomized controlled trial with a non-inferiority design. Economic evaluation alongside a randomized controlled multi-center trial.

Study population: all consecutive patients aged between 65 years and older with displaced intra-articular (AO Type C) distal radius fractures, with a not acceptable reduction within 3 weeks following trauma.

Intervention: patients will be randomized between open reduction and internal fixation (intervention group) and plaster immobilization (control group).

Main study parameters: the primary outcome will be evaluated after 1 year with the Patient-Rated Wrist Evaluation score (PRWE). Secondary outcomes comprise other patient reported outcome measures (PROM) including the Disability of the Arm, Shoulder and Hand (DASH), Quality of life (EQ-5D) and Pain Catastrophizing Scale (PCS). Further outcome measurements comprise a costs evaluation questionnaire, range of motion (ROM), grip strength, radiographic parameters and Complications.

03

Conditions studied

  • Radius Distal Fracture

Browse trials for

Keywords

  • elderly
  • intra articular
  • RCT
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • > 65 years at time of trauma
  • Intra-articular distal radius fracture (AO type C*)
  • One or more of the following fracture characteristics within 3 weeks post-trauma (including secondary dislocation):

    ≤15° inclination \<5 mm radial length >15° dorsal tilt >20° volar tilt intra-articular gap or step-off >2 mm

  • \< 3 weeks post trauma
  • Living independent
  • Fit for surgery
  • Mentally competent
  • Dutch fluency and literacy

Exclusion criteria

Exclusion Criteria:

  • Open fractures
  • Neurovascular damage
  • Multiple-trauma patients (ISS >16)
  • Other fractures in the injured extremity other than ulnar styloid process fractures
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
138 participants (actual)

Study arms

  • Experimental
    Open reduction internal fixation

    Surgical open reduction internal fixation (ORIF)

    Procedure: Surgery (Open Reduction Internal Fixation)

  • Active comparator
    Plaster immobilization

    Standard local hospital protocol for cast treatment

    Procedure: Cast treatment

Interventions

  • ProcedureSurgery (Open Reduction Internal Fixation)

    Either volar of dorsal plating or both

    Also known as: ORIF Open Reduction Internal Fixation

  • ProcedureCast treatment

    Hospitals may use their preferred protocol

    Also known as: Plaster

06

What researchers measure

Primary outcomes

  1. PRWE

    Patient-Rated Wrist Evaluation score

    Time frame: 12 months

Secondary outcomes

  1. DASH

    Disability of the Arm, Shoulder and Hand

    Time frame: 12 months

  2. EQ/5D

    Quality of life

    Time frame: 12 months

  3. PCS

    Pain Catastrophizing Scale

    Time frame: 12 months

Other outcomes

  1. ROM

    range of motion

    Time frame: 12 months

  2. grip strength

    grip strength of both wrists

    Time frame: 12 months

  3. Radiographic parameters

    Radial inclination, volar/dorsal tilt, ulnar variance, gap, step off and radial length

    Time frame: 6 months

  4. Complications

    Complications of either treatment arm

    Time frame: 12 months

07

Study locations

1 site
  • Onze Lieve Vrouwe Gasthuis
    Amsterdam, North Holland 1090 HM, Netherlands
08

References and documents

Publications

  • Ter Meulen DP, Mulders MAM, Kruiswijk AA, Kret EJ, Slichter ME, van Dongen JM, Kerkhoffs GMMJ, Goslings JC, Kleinlugtenbelt YV, Willigenburg NW, Schep NWL, Poolman RW; DART Study Group. Effectiveness and cost-effectiveness of surgery versus casting for elderly patients with Displaced intra-Articular type C distal Radius fractures: protocol of a randomised controlled Trial with economic evaluation (the DART study). BMJ Open. 2022 Apr 1;12(4):e051658. doi: 10.1136/bmjopen-2021-051658. PubMed 35365511 ↗

Related links

Individual participant data

Plan to share: Yes

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2017 to primary completion in Nov 2022, 69 months.

Of 126 non-industry interventional studies with no phase under Wrist Fractures, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 50. This study's 69 months is above that.

Counting every sponsor, half of 127 studies reached it within 25 months; a quarter within 16 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 22, 2016
First posted
Jan 4, 2017
StartActual
Feb 1, 2017
Primary completionActual
Nov 1, 2022
CompletionActual
Nov 1, 2022
Last update
Jan 18, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03009890
Lead sponsor
JointResearch
Collaborators
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Maasstad Hospital, Deventer Ziekenhuis
Responsible party
Sponsor
First posted
Jan 4, 2017
Start date
Feb 1, 2017
Primary completion
Nov 1, 2022
Completion
Nov 1, 2022
Last update
Jan 18, 2023

Study contacts

Rudolf W Poolman, Prof. MD PhD
principal investigator · OLVG, Amsterdam, the Netherlands

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion